ESC Premium Access

Effect of prophylactic and therapeutic low molecular weight heparins on mortality in 15,704 COVID-19 patients. A systematic review and a meta-analysis.

Presentation

About the speaker

Doctor Arianna Pani

University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)
0 follower

4 more presentations in this session

Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19).

Speaker: Doctor F. Santoro (Foggia, IT)

Thumbnail

Early experience utilizing bivalirudin as anticoagulation in extracorporeal membrane oxygen in coronavirus disease 2019

Speaker: Doctor C. Jones (West Palm Beach, US)

Thumbnail

Effect of statins on mortality in patients with COVID-19: an updated meta-analysis of 147824 patients

Speaker: Doctor C. Diaz-Arocutipa (Lima, PE)

Thumbnail

Management and impact of atrial fibrillation in the COVID 19 era; concomitancy of two procoagulant phenomena

Speaker: Doctor A. Arteagoitia Bolumburu (Madrid, ES)

Thumbnail

Access the full session

COVID-19 and cardiovascular pharmacotherapy

Speakers: Doctor A. Pani, Doctor F. Santoro, Doctor C. Jones, Doctor C. Diaz-Arocutipa, Doctor A. Arteagoitia Bolumburu
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Heart failure as a complication of covid-19 infection: systematic review and meta-analysis

27 August 2021

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

ESC Premium Access

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

27 August 2021

This platform is supported by

logo Novo Nordisk